Century Therapeutics Income Tax

Century Therapeutics (IPSC) currently reports a income tax of $-68K as of June 2026. That compares with $1.8M in the prior-year period — down 103.8% year over year. Use the charts on this page to explore Century Therapeutics's income tax history and peer comparisons.

Century Therapeutics's income tax decreased from $1.8M to $-68K — a 103.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Century Therapeutics reported $-68K in income tax as of June 2026. That compares with $1.8M in the prior-year period — down 103.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current income tax of $-68K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Century Therapeutics, and consider following IPSC for alerts when major investors trade the stock.

Century Therapeutics is classified in the Healthcare sector. On income tax, it currently shows $-68K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IPSC with unrelated industries.